#03 Covid Zone 1- Coronavirus literature updates 30th March 2020

Welcome to the COVID-ZONE. 
Journalspotting is here to bring you important clinical updates on coronavirus.
Get in touch: journalspotting@gmail.com
Twitter @JournalSpotting

In today's episode:

#ACE inhibitors and angiotensin receptor blockers- do they worsen COVID-19? 
https://doi.org/10.1016/j.cell.2020.02.052 
ESC position statement 

#The NSAID controversy 
https://doi.org/10.1016/S2213-2600(20)30116-8 
EMA statement 
French pharmacovigilance of ibuprofen 
MHRA alert  
Indomethacin and SARS CoV-1 

#Lopinavir/Ritonavir falls at the first hurdle 
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2001282?articleTools=true 

#Chloroquine/Hydroxychloroquine get a big endorsement 
Systematic review on the efficacy and safety of chloroquine for treatment of COVID-19 
Letter in Bioscience trends 10.5582/bst.2020.01047 
In vitro study of chloroquine: https://www.nature.com/articles/s41422-020-0282-0 

#How good are the swabs? 
https://jamanetwork.com/journals/jama/fullarticle/2762997 

#Anosmia is the new normal: Will I ever smell again? 
https://www.entnet.org/content/coronavirus-disease-2019-resources 

#Coronavirus likes plastic, hates pennies: which surfaces should I be wiping down? 
https://pubmed.ncbi.nlm.nih.gov/32182409/ 

#Modelling studies that matter   
https://www.bmj.com/content/bmj/368/bmj.m1216.full.pdf 
https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/ 
Oxford modelling  

#Covert COVID Distractions 
Because isolation can bring out a sense of humour in us, and we all need a distraction!